There is no difference between groups in severity, length of stay and ICU or hospital mortality in this group of patients.
On one-way ANOVA there was no difference between groups in path length (F = 1.14, P > 0.05), number of lines crossed (F = 0.94, P > 0.05), speed (F = 1.14, P > 0.05), exploration levels (F = 0.56, P > 0.05, grooming events (F = 0.21, P > 0.05), and the ratio of time spend in the centre of the arena to the periphery (F = 0.07, P > 0.05) (data not shown).
On one-way ANOVA there was no difference between groups in path length (F = 1.99, P > 0.05), number of lines crossed (F = 1.59, P > 0.05), speed (F = 1.99, P > 0.05), exploration levels (F = 0.29, P > 0.05), grooming events (F = 0.85, P > 0.05), or the ratio of time spent in the centre of the arena to the periphery (F = 1.29, P > 0.05) (data not shown).
There were no significant differences between groups in laboratory measures, length of hospital stay or spirometry at discharge (Table 3).> -wrap-foot> aC-reactivective protein; FEV1, Forced expiratory volume in 1 second; PCT, procalcitonin; WBC, white blood cells.
There were no significant differences at birth between groups in gestational age, weight, length, and head circumference or in weight, length, head circumference, MUAC, or triceps skinfold thickness at 2, 13, or 52 wk of age.
Substantial differences were observed between groups in the number and length of LD blocks in the targeted regions.
The differences between groups in terms of mortality and length of stay are represented in Figure 3.
There were no significant differences between groups in patient age, sex, race, length of stay, or primary diagnosis.
No significant differences between groups in the incidence of complications, length of stay in the ICU and in the hospital were noted.
